DS79932728
DS79932728 is an orally active inhibitor for G9a and GLP with IC50 of 12.6 nM and 75.7 nM. DS79932728 induces the production of γ-globin, thereby increasing the level of fetal hemoglobin (HbF) . DS79932728 increases F-reticulocytes (F-rets) proportion and exhibits good oral absorption characteristics in cynomolgus monkey models[1].
Product Specifications
CAS Number
2757191-62-9
UNSPSC
12352005
Target
GLP Receptor; Histone Methyltransferase
Related Pathways
Epigenetics; GPCR/G Protein
Field of Research
Others
Smiles
NC1=NC2=CC(C3=CCN(C)CCC3)=C(OC)C=C2C14CCC4
Molecular Formula
C19H25N3O
Molecular Weight
311.42
References & Citations
[1]Katayama K, et al., Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease. ACS Med Chem Lett. 2020 Dec 28;12 (1) :121-128.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV751491 1.0 µg DNA
TRNAD8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 
MBS6284149-02 5x 0.2 mL
CDH24, NT (CDH24, CDH11L, Cadherin-24) (AP)
Sign In for Pricing
View Details 
VAng-Lsx09842-1mgEcoli 1 mg (E. coli)
Recombinant Shigella Sonnei lpxC Protein (aa 1-305)
Sign In for Pricing
View Details